APA (7th ed.) Citation

Brion, R., Gantier, M., Biteau, K., Taurelle, J., Brounais-Le Royer, B., Verrecchia, F., . . . Guiho, R. (2022). TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment. Cancers, 14(22), 5627. https://doi.org/10.3390/cancers14225627

Chicago Style (17th ed.) Citation

Brion, Régis, Malika Gantier, Kevin Biteau, Julien Taurelle, Bénédicte Brounais-Le Royer, Franck Verrecchia, Françoise Rédini, and Romain Guiho. "TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment." Cancers 14, no. 22 (2022): 5627. https://doi.org/10.3390/cancers14225627.

MLA (9th ed.) Citation

Brion, Régis, et al. "TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment." Cancers, vol. 14, no. 22, 2022, p. 5627, https://doi.org/10.3390/cancers14225627.